MapLight Therapeutics, Inc. ( MPLT )

Other

Voting Common Stock

2,733,681

-^{footnote F1}

Oct 28, 2025

Open-market purchase

Voting Common Stock

952,941^{footnote F2}

$17.00

$16.20M

Oct 28, 2025

Other

Series C Preferred Stock

26,191,207

$0.00

Oct 28, 2025

Other

Series D Preferred Stock

19,734,671

$0.00

Footnote F1 (price): The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F2 (shares): Represents a purchase from the underwriters in the Issuer's initial public offering.

Oct 28, 2025

Other

Voting Common Stock

14,256,288

-^{footnote F1}

Oct 28, 2025

Open-market purchase

Voting Common Stock

5,441,176

$17.00

$92.50M

Oct 28, 2025

Other

Series A Preferred Stock

148,809

-^{footnote F3}

Oct 28, 2025

Other

Series A-1 Preferred Stock

444,846

-^{footnote F4}

Oct 28, 2025

Other

Series B Preferred Stock

1,263,768

-^{footnote F5}

Oct 28, 2025

Other

Series B-1 Preferred Stock

275,148

-^{footnote F6}

Oct 28, 2025

Other

Series C Preferred Stock

5,444,807

-^{footnote F7}

Oct 28, 2025

Other

Series D Preferred Stock

6,678,910

-^{footnote F8}

Footnote F1 (price): The Series A, A-1, B, B-1, C and D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F3 (price): The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F4 (price): The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F5 (price): The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.
Footnote F6 (price): The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F7 (price): The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Footnote F8 (price): The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.

Oct 27, 2025

Vishwas Setia - Officer

Grant or award

Voting Common Stock

43,367^{footnote F1}

$0.00^{footnote F2}

Oct 27, 2025

Vishwas Setia - Officer

Grant or award

Employee Stock Option (right to buy)

176,031

$0.00

Footnote F1 (shares): Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Oct 27, 2025

Anatol Kreitzer - Officer

Grant or award

Employee Stock Option (right to buy)

146,052

$0.00

Oct 27, 2025

Anatol Kreitzer - Officer

Grant or award

Voting Common Stock

35,953^{footnote F1}

$0.00^{footnote F2}

Footnote F1 (shares): Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Oct 27, 2025

Erin Pennock Foff - Officer

Grant or award

Voting Common Stock

48,275^{footnote F1}

$0.00^{footnote F2}

Oct 27, 2025

Erin Pennock Foff - Officer

Grant or award

Employee Stock Option (right to buy)

196,035

$0.00

Footnote F1 (shares): Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting… Full note on SEC EDGAR
Footnote F2 (price): Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Oct 27, 2025

Grant or award

Employee Stock Option (right to buy)

139,610

$0.00

Oct 28, 2025

Other

Series C Preferred Stock

65,477

$0.00

Oct 27, 2025

Grant or award

Voting Common Stock

34,390^{footnote F1}

$0.00^{footnote F2}

Oct 28, 2025